Activation of NQO-1 mediates the augmented contractions of isolated arteries due to biased activity of soluble guanylyl cyclase in their smooth muscle
- 97 Downloads
Earlier studies on isolated arteries demonstrated that the para-quinone thymoquinone, like acute hypoxia, induces augmentation of contractions, depending on biased activity of soluble guanylyl cyclase (sGC), generating inosine-3′,5′-cyclic monophosphate (cyclic IMP) rather than guanosine-3′,5′-cyclic monophosphate (cyclic GMP). NAD(P)H:quinone oxidoreductase 1 (NQO-1), the enzyme responsible for biotransformation of quinones into hydroquinones, was examined for its involvement in these endothelium-dependent augmentations, establishing a link between the metabolism of quinones by NQO-1 and biased sGC activity. Isolated arteries of Sprague-Dawley rats (aortae and mesenteric arteries) and farm pigs (coronary arteries) were studied for measurement of changes in tension and collected to measure NQO-1 activity or its protein level. β-lapachone, an ortho-quinone and hence substrate of NQO-1, increased the activity of the enzyme and augmented contractions in arteries with endothelium. This augmentation was inhibited by endothelium removal and inhibitors of endothelial NO synthase (eNOS), sGC, or NQO-1; in preparations without endothelium or treated with an eNOS inhibitor, it was restored by the NO donor DETA NONOate and by ITP and cyclic IMP, revealing biased sGC activity as the underlying mechanism, as with thymoquinone. Hydroquinone, the end product of quinone metabolism by NQO-1, augmented contractions depending on sGC activation but in an endothelium-independent manner. In coronary arteries, repeated acute hypoxia caused similar augmentations as those to quinones that were inhibited by the NQO-1 inhibitor dicoumarol. Augmentations of contraction observed with different naturally occurring quinones and with acute hypoxia are initiated by quinone metabolism by NQO-1, in turn interfering with the NO/biased sGC pathway, suggesting a possibly detrimental role of this enzyme in ischemic cardiovascular disorders.
KeywordsVasoconstriction Biased soluble guanylyl cyclase (sGC) activity Cyclic IMP Quinones Hydroquinone Hypoxic augmentation NAD(P)H:quinone oxidoreductase 1 (NQO-1)
- Cyclic GMP
- Cyclic IMP
- DETA NONOate
Endothelial nitric oxide synthase
Nω-nitro-l-arginine methyl ester hydrochloride
NAD(P)H:quinone oxidoreductase 1
Reactive oxygen species
Sodium dodecyl sulfate
Soluble guanylyl cyclase
The authors would like to thank Ms. Yee Har Chung and Mr. Godfrey Man for their excellent technical assistance and Ms. Ivy Wong for her editorial and administrative support.
CD, SL, and PV conceived and designed the research. CD conducted the experiments and analyzed the data. CD, SL, and PV wrote the manuscript. All authors read and approved the final version of the manuscript.
This work was supported by the Health and Medical Research Fund  of the Food and Health Bureau of the Government of the Hong Kong Special Administrative Region and by the General Research Fund  of the Hong Kong Research Grant Council.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.
- Bey EA, Wuerzberger-Davis SM, Pink JJ, Yang CR, Araki S, Reinicke KE, Bentle MS, Dong Y, Cataldo E, Criswell TL, Wagner MW, Li L, Gao J, Boothman DA (2006) Mornings with art, lessons learned: feedback regulation, restriction threshold biology, and redundancy govern molecular stress responses. J Cell Physiol 209:604–610CrossRefGoogle Scholar
- Black SR, Fennell TR, Mathews JM, Snyder RW, Patel PR, Watson SL et al (2017) Disposition of [14C]hydroquinone in Harlan Sprague-Dawley rats and B6C3F1/N mice: species and route comparison. Xenobiot 22:1–14Google Scholar
- Choi EK, Terai K, Ji IM, Kook YH, Park KH, Oh ET, Griffin RJ, Lim BU, Kim JS, Lee DS, Boothman DA, Loren M, Song CW, Park HJ (2007) Upregulation of NAD(P)H:quinone oxidoreductase by radiation potentiates the effect of bioreductive beta-lapachone on cancer cells. Neoplasia 9:634–642CrossRefGoogle Scholar
- Kim YH, Hwang JH, Kim KS, Noh JR, Gang GT, Seo Y, Nam KH, Kwak TH, Lee HG, Lee CH (2015a) NAD(P)H:quinone oxidoreductase 1 activation reduces blood pressure through regulation of endothelial nitric oxide synthase acetylation in spontaneously hypertensive rats. Am J Hypertens 28:50–57CrossRefGoogle Scholar